Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Flu illness count nears 5 million, with New York City among the hardest hit - 2Winter virus season so far is not too bad, but doctors worry about suffering to come
- 3She just became the first wheelchair user to travel to space
- 4Bruno Mars tour 2026: How to get tickets for 'The Romantic Tour,' presale times, prices and more
- 5‘We are the alternative’: Anti-Hamas Gaza militia tells BBC group is receiving international support
- She was the supermodel dubbed 'The Face' in the '80s. Joining OnlyFans in her 60s taught her a lot.
- Israeli police block Latin Patriarch from Palm Sunday mass in Jerusalem
- Study reveals links between global food systems, obesity, and climate change
- IDF begins destroying homes used by Hezbollah as forces move deeper into southern Lebanon
- See as Your #1: These Low-Sugar Food sources You Ought to Attempt
- Significant Elements to Consider Prior to Applying for a Mastercard: 6 Vital Contemplations
- Nestlé says 413,793 KitKat candy bars stolen en route from Italy to Poland
- Well known Travel Booking Locales: What's Your Pick?
- The powerful new Rubin Observatory just found 11,000 new asteroids and measured 'tens of thousands more'
